How Small & Mid-Sized Drug Companies Can Implement an Effective Anti-Counterfeiting Strategy

Download the White Paper

Counterfeit and Diverted Medicines Can Cause Severe Damage to Public Health and Brand Reputation

Understand the key considerations to implement an anti-counterfeiting strategy during the early stages of drug production to protect patients and products from unnecessary risk

Counterfeit, adulterated and diverted medicines present a critical risk to patient safety and account for hundreds of billions of dollars in global illicit trade.

Larger companies commonly develop more advanced anti-counterfeit program (ACP) solutions in the early stages of production. Small- and mid-sized companies, however, often do not have the management bandwidth to handle the scale of these larger strategies, so leave it until later in the commercialization process when the potential risks in the market have become more known.

Waiting until the later stages of the production process to implement proper risk assessment and a product protection solution can put patients at significant risk, as well as severely and adversely impacting any company’s financial success, brand reputation and capacity to manage crisis events in the supply chain.

Protect what matters most – Customers. Brand. Revenue.

Download the White Paper

  • Fuel authentication program helps Serbia recover
    millions in lost excise taxes

    More than 930 million liters of fuel marked, and the Serbian government began to see significant evidence that the program was working.

    Read Case Study

  • Major US Fuel Marketer Protects its Brand Promise
    and Revenue Stream

    The oil company has experienced a 7% decrease in failure rate directly attributed to a reduction in the commingling of non-branded gasoline with branded product.

    Read Case Study

  • Level 3 Security Features and Currency

    Counterfeiting put one of the world’s largest economies at risk when rates reached nearly 300 counterfeits per million notes.

    Read Case Study

  • How One Country Increased Excise Tax Collection

    Learn how one African nation overcame under reporting of production volumes and product smuggling of tobacco, spirits, beer, soda and bottled water.

    Read Case Study

  • Pharmaceutical Counterfeits Threaten $1 Billion Pipeline of Product

    Counterfeit copies of major pharmaceutical brand were discovered in the US market. With no security measures in place to allow patients or inspectors to easily identify counterfeit goods.

    Read Case Study